Pacific Biosciences
PACB
$11.33
Share price
-2.16%
Change (1 day)
2.91%
Change (1 year)
Earnings for Pacific Biosciences (PACB)
Earnings in 2022 (TTM): -$0.3 B
According to Pacific Biosciences 's latest financial reports the company's current earnings (TTM) are -$0.3 B. In 2021 the company made an earning of -$0.28 B a decrease over its 2020 earnings that were of $29.4 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Pacific Biosciences from 2010 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.3 B | 8.42% |
| 2021 | -$0.28 B | -1034.84% |
| 2020 | $29.4 M | -134.95% |
| 2019 | -$84.14 M | -17.97% |
| 2018 | -$0.11 B | 11.25% |
| 2017 | -$92.19 M | 23.95% |
| 2016 | -$74.38 M | 134.65% |
| 2015 | -$31.7 M | -52.09% |
| 2014 | -$66.16 M | -16.56% |
| 2013 | -$79.3 M | -15.99% |
| 2012 | -$94.39 M | -14.01% |
| 2011 | -$0.11 B | -21.65% |
| 2010 | -$0.15 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $7.92 B | -2,759.57% | 🇺🇸 USA |
 General Electric GE | $3.15 B | -1,157.32% | 🇺🇸 USA |
 Illumina ILMN | -$4.06 B | 1,259.65% | 🇺🇸 USA |
 PerkinElmer
PKI | $0.83 B | -380.48% | 🇺🇸 USA |
 Luminex LMNX | N/A | N/A | 🇺🇸 USA |
 NanoString Technologies NSTG | -$0.14 B | -54.11% | 🇺🇸 USA |